Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Cash flows from operating activities:
Net income (loss)	$ 4,947,859	$ (49,851,140)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Depreciation and amortization	605,796	626,077
Amortization of debt issuance costs	587,750	2,043,458
Loss on issuance of warrants		43,541,211
Provision for credit losses		608,356
Gain on sale		5,897
Share-based compensation	33,938
Amortization of prepaid share-based compensation	111,000
Gain on forgiveness of interest	(3,006,896)
Gain on forgiveness of earnout	(6,100,000)
Changes in assets and liabilities:
Accounts receivable	(679,695)	(1,482,070)
Inventories	835,443	(3,323,971)
Prepaid expenses and other current assets	72,408	749,086
Accounts payable	(270,193)	(159,375)
Accrued expenses and other current liabilities	2,139,298	2,305,191
Net cash used in operating activities	(723,292)	(4,937,282)
Cash flows from investing activities:
Purchases of property and equipment		(36,307)
Investment in developed technology		(77,491)
Proceeds from sale of property and equipment		181,000
Net cash provided by investing activities		67,202
Cash flows from financing activities:
Net proceeds from issuance of common stock	710,000	14,598
Net borrowings under convertible notes		3,150,000
Net borrowings under line of credit	575,000
Fees paid for financing costs		(664,389)
Net cash provided by (used in) financing activities	(3,715,767)	2,383,909
Net increase (decrease) in cash and cash equivalents	(4,439,059)	(2,486,171)
Cash and cash equivalents, beginning of the year	5,247,836	5,580,431
Cash and cash equivalents, end of the period	808,777	3,094,260
Supplemental disclosure of cash flow information:
Cash paid for interest	268,500	444,781
Cash paid for income taxes
Issuance of warrants to noteholders and placement agent		4,335,611
Issuance of common stock to line of credit holders	60,000
Issuance of common stock to vendors for future services	387,000
Issuance of common stock to employees and directors for settlement of liabilities	262,916
Issuance of common stock to vendors for settlement of liabilities	105,693
Issuance of common stock to noteholders for settlement of accrued interest	1,148,000
Issuance of common stock to noteholders for settlement of cash warrant liabilities	206,779
Original issue discount		555,000
Convertible shares under notes payable	99,199	7,743,333
Nonrelated Party [Member]
Cash flows from financing activities:
Repayments under convertible notes payable – related parties	(4,915,000)
Related Party [Member]
Cash flows from financing activities:
Repayments under convertible notes payable – related parties	$ (85,767)	$ (116,300)